312 related articles for article (PubMed ID: 33270909)
1. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
Balachandra S; Kusin SB; Lee R; Blackwell JM; Tiro JA; Cowell LG; Chiang CM; Wu SY; Varma S; Rivera EL; Mayo HG; Ding L; Sumer BD; Lea JS; Bagrodia A; Farkas LM; Wang R; Fakhry C; Dahlstrom KR; Sturgis EM; Day AT
Cancer; 2021 Mar; 127(6):850-864. PubMed ID: 33270909
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N; Kamath V; Bhat PV; Bhatt P; Arunkumar G
Asian Pac J Cancer Prev; 2021 May; 22(5):1351-1364. PubMed ID: 34048162
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Kreimer AR; Brennan P; Lang Kuhs KA; Waterboer T; Clifford G; Franceschi S; Michel A; Willhauck-Fleckenstein M; Riboli E; Castellsagué X; Hildesheim A; Fortner RT; Kaaks R; Palli D; Ljuslinder I; Panico S; Clavel-Chapelon F; Boutron-Ruault MC; Mesrine S; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Cross AJ; Bueno-de-Mesquita HB; Vineis P; Larrañaga N; Pala V; Sánchez MJ; Navarro C; Barricarte A; Tumino R; Khaw KT; Wareham N; Boeing H; Steffen A; Travis RC; Quirós JR; Weiderpass E; Pawlita M; Johansson M
J Clin Oncol; 2015 Mar; 33(8):877-84. PubMed ID: 25667279
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
8. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
9. Case-control study of human papillomavirus and oropharyngeal cancer.
D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
[TBL] [Abstract][Full Text] [Related]
10. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
Lang Kuhs KA; Wood CB; Wiggleton J; Aulino JM; Latimer B; Smith DK; Bender N; Rohde S; Mannion K; Kim Y; Sinard R; Langerman A; Fleischer A; Fakhry C; Waterboer T; Netterville JL
Cancer; 2020 Jun; 126(11):2658-2665. PubMed ID: 32129894
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
12. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
13. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
16. The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.
Otter S; Whitaker S; Chatterjee J; Stewart A
Clin Oncol (R Coll Radiol); 2019 Feb; 31(2):81-90. PubMed ID: 30385006
[TBL] [Abstract][Full Text] [Related]
17. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
[TBL] [Abstract][Full Text] [Related]
18. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
